"
Conditions
Interventions
Anma (Anma group) In study 1, the VAS values of VAS paper (up to 100 mm) separated before and after Amma treatment were used to draw a vertical line before and after Amma treatment to record the &quo
Katakori"
condition. The VAS values were compared before and after Anma treatment. In study 2, in the Anma group, 1 minute before the Anma treatment (Pre), immediately after the end of Anma treatment (Post 0),
the body position was in the lateral decubitus position (left to right), and the treatment site was performed in the order of (1) cervical portion (2) upper shoulder region (3) upper limb (4) intersca
stroking
Sponsors
National University Corporation Tsukuba University of Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Adults aged 20-80 (2)Those who are aware of "Katakori" (3)Those who can participate in the research schedule
Exclusion criteria
Exclusion criteria: (1)No muscle or bone disease (cervical arm syndrome, frozen shoulder, low back pain osteoarthritis, etc.) (2)No gastrointestinal disorders (gastritis, gastric/duodenal ulcer, etc.) (3)No cardiovascular disease (angina, etc.)/respiratory disease (bronchial asthma, bronchitis, etc.) (4)Diabetes (5)Malignant tumor (6)Those who are pregnant or breastfeeding (7)No history of contact dermatitis due to an adhesive tape.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog scale (VAS) In study 1, the VAS values of VAS paper (up to 100 mm) separated before and after Amma treatment were used to draw a vertical line before and after Amma treatment to record the "Katakori" condition. The VAS values were compared before and after Anma treatment. In study 3, both the Anma group and the control group were (1) 7 days before Anma (Before 7), (2) immediately before Anma (Before), (3) 7th day after Anma (After 7), (4) Anma after the completion of the implementation (After 14) and the seventh day after the completion of (5) Anma (After 21), a total of 5 measurements were performed. As above mentioned, VAS values were measured before Amma treatment, and after resting for 10 minutes in the supine position, MBV was measured for 1 minute and sampled for 5 seconds for analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Near infrared spectroscopy (NIRS) In study 2, in the Anma group, 1 minute before the Anma treatment (Pre), immediately after the end of Anma treatment (Post 0), 1 minute later (Post 1), 2 minutes later (Post 2), 3 minutes later (Post 3), 4 minutes later (Post 4), 5 minutes later (Post 5), 6 minutes later (Post 6), 7 minutes later (Post 7), 8 minutes later (Post 8), 9 minutes later (Post 9) , we measured MBV. In study 3, both the Anma group and the control group were (1) 7 days before Anma (Before 7), (2) immediately before Anma (Before), (3) 7th day after Anma (After 7), (4) Anma after the completion of the implementation (After 14) and the seventh day after the completion of (5) Anma (After 21), a total of 5 measurements were performed. As above mentioned, VAS values were measured before Amma treatment, and after resting for 10 minutes in the supine position, MBV was measured for 1 minute and sampled for 5 seconds for analysis. | — |
Countries
Japan
Contacts
Public Contacthiroshi kuge
Osaka Medical College Hospital Department of Anesthesiology Pain Clinic
Outcome results
None listed